Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 1
2003 3
2004 2
2006 1
2007 1
2008 1
2010 2
2011 3
2012 1
2013 2
2014 1
2015 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year
Filters applied: . Clear all
Page 1
A meta-analysis of the reliability of the history in suspected poisoning.
Camilleri R. Camilleri R. J Emerg Med. 2015 Jun;48(6):679-84. doi: 10.1016/j.jemermed.2014.12.067. Epub 2015 Mar 28. J Emerg Med. 2015. PMID: 25827782 Review.
Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.
Liechti M. Liechti M. Swiss Med Wkly. 2015 Jan 14;145:w14043. doi: 10.4414/smw.2015.14043. eCollection 2015. Swiss Med Wkly. 2015. PMID: 25588018 Free article. Review.
Utilization management in toxicology.
Zhang Y, Kwong TC. Zhang Y, et al. Clin Chim Acta. 2014 Jan 1;427:158-66. doi: 10.1016/j.cca.2013.09.039. Epub 2013 Sep 30. Clin Chim Acta. 2014. PMID: 24091099 Review.
MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; 'sparkle'; 'mindy') toxicity: a brief overview and update.
Corkery JM, Elliott S, Schifano F, Corazza O, Ghodse AH. Corkery JM, et al. Hum Psychopharmacol. 2013 Jul;28(4):345-55. doi: 10.1002/hup.2298. Hum Psychopharmacol. 2013. PMID: 23881883 Review.
Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions.
Rietjens SJ, Hondebrink L, Westerink RH, Meulenbelt J. Rietjens SJ, et al. Crit Rev Toxicol. 2012 Nov;42(10):854-76. doi: 10.3109/10408444.2012.725029. Epub 2012 Oct 3. Crit Rev Toxicol. 2012. PMID: 23030234 Review.
Clinical toxicology of newer recreational drugs.
Hill SL, Thomas SH. Hill SL, et al. Clin Toxicol (Phila). 2011 Oct;49(8):705-19. doi: 10.3109/15563650.2011.615318. Clin Toxicol (Phila). 2011. PMID: 21970769 Review.
Status and trends in poisonings in Denmark 2007-2009.
Bøgevig S, Høgberg LC, Dalhoff KP, Mortensen OS. Bøgevig S, et al. Dan Med Bull. 2011 May;58(5):A4268. Dan Med Bull. 2011. PMID: 21535985
Morbidity associated with MDMA (ecstasy) abuse: a survey of emergency department admissions.
Halpern P, Moskovich J, Avrahami B, Bentur Y, Soffer D, Peleg K. Halpern P, et al. Hum Exp Toxicol. 2011 Apr;30(4):259-66. doi: 10.1177/0960327110370984. Epub 2010 May 20. Hum Exp Toxicol. 2011. PMID: 20488845
[Adulterated alcoholic beverages].
Magnúsdóttir K, Kristinsson J, Jóhannesson B. Magnúsdóttir K, et al. Laeknabladid. 2010 Oct;96(10):626-8. doi: 10.17992/lbl.2010.10.322. Laeknabladid. 2010. PMID: 20959682 Free article. Icelandic.
Liquid ecstasy - a significant drug problem.
Andresen H, Stimpfl T, Sprys N, Schnitgerhans T, Müller A. Andresen H, et al. Dtsch Arztebl Int. 2008 Sep;105(36):599-603. doi: 10.3238/arztebl.2008.0599. Epub 2008 Sep 5. Dtsch Arztebl Int. 2008. PMID: 19471624 Free PMC article.
17 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback